Rebuilding an AAC interface around accessible communication, caregiver context, and the path from first use to a useful daily habit.
Choose a communicator or caregiver path. Explore boards, cards, phrase building, and the voice and sharing ideas in this self-contained v3 prototype.
Sample data and exploratory flows · separate from LoriComunica’s production app.
Open the Lori prototype
This is the current public website. The case study below focuses on my contribution during the project.
LoriComunica helps people with speech or motor impairments communicate. Research and prototype testing exposed a mismatch between the product’s capabilities and what people could actually discover and use. Separate board and card management, onboarding friction, and caregiver needs made a capable tool harder to adopt.
I rebuilt the interface around a clearer first-run journey, accessible boards, and a unified way to make and use cards. The goal was to let someone reach a meaningful communication action before setup complexity took over.
The interactive v3 prototype explores role selection, caregiver views, custom cards, phrase building, board sharing, and voice experiences. It makes the research decisions tangible enough to test and discuss.
I also worked on Python/FastAPI/PostgreSQL backend prototypes, clinic field testing, localized delivery considerations, and a 12-month US/Brazil clinic partnership plan.
Explanatory system view · reconstructed from the project
I led the research-informed UI overhaul and built the interactive front-end prototype provided here. I also contributed backend prototypes and worked through the product and partner questions around adoption.
The UX overhaul recorded 93% user preference in the project research. The working prototype shows the revised interaction model and supports discussion of communication and caregiver flows; the team also produced a clinic go-to-market plan.
The linked prototype is an exploratory demonstration with sample data, not LoriComunica’s production app. Preference is an experience measure, not a claim of clinical efficacy or realized paid conversion. Features explored in the prototype should not be read as shipped product features.
A second set of eyes. A human final call.